Exploring Emerging Trends in Medical Glaucoma Management - Podcast
Media formats available:
Details
Presenters
Overview
This podcast focuses on the newest therapies in glaucoma management and how their mechanisms of action and efficacy compares to traditional prostaglandins. The podcast also includes case discussions. This activity is supported by an unrestricted educational grant from Aerie. Learning Objectives
Upon completion of this activity, the participant should be able to: - Describe the mechanisms of action of novel therapeutics and classes of drugs
- Compare the efficacy of novel therapeutics with traditional prostaglandins
- Understand and explain the likelihood of achieving target intraocular pressure with monotherapy compared with combination regimens
- Restate the most common side effects of novel therapeutics
- Identify how to provide the best possible collaborative care when comanaging patients
Accreditation
This podcast has no credit associated with it. Faculty and Disclosures
DISCLOSURE POLICY
DISCLOSURE POLICY It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity. The following faculty/staff members have the following financial relationships with commercial interests:Jacob W. Brubaker, MD, and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Allergan, Glaukos, Ivantis, and New World Medical. Grant/Research Support: Aerie, Allergan, Equinox, Glaukos, Ivantis, Nicox and Santen. Speakers Bureau: Aerie, and Allergan. Oluwatosin U. Smith, MD and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Allergan, Glaukos, Iridex, and New World Medical. Grant/Research Support: Allergan, Glaukos, and Santen. Speaker’s Bureau: Aerie, Allergan, and Bausch + Lomb. The Evolve staff and planners have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Disclaimer
OFF-LABEL STATEMENT This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. DISCLAIMER The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Aerie. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!